Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Replications, ridicule and a recluse: the controversy over NgAgo gene-editing intensifies

This article has been updated

As failures to replicate results using the CRISPR alternative stack up, a quiet scientist stands by his claims.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 09 August 2016

    This story has been updated since it was first posted to include the revised protocol that Han released on 8 August, and comments on the protocol from Lluís Montoliu and Gaetan Burgio.

Authors

Additional information

Additional reporting by Heidi Ledford

Tweet Facebook LinkedIn Weibo Wechat

Related links

Related links

Related links in Nature Research

Beyond CRISPR: A guide to the many other ways to edit a genome 2016-Aug-08

Chinese scientists to pioneer first human CRISPR trial 2016-Jul-21

CRISPR, the disruptor 2015-Jun-03

Chinese scientists genetically modify human embryos 2015-Apr-22

Nature special: CRISPR

Nature special: Science in China

Outlook: Gene editing

Related external links

Chunyu Han lab page on Addgene

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cyranoski, D. Replications, ridicule and a recluse: the controversy over NgAgo gene-editing intensifies. Nature 536, 136–137 (2016). https://doi.org/10.1038/536136a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/536136a

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research